Kamran Alam Taysha Gene Therapies, Inc. (TSHA) insider trading activity

TSHA Quotes by TradingView

Kamran Alam is CHIEF FINANCIAL OFFICER of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 1.27 Million shares of TSHA, which is worth approximately $2.35 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 431,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.27M
51.25% 3M change
51.02% 12M change
Total Value Held $2.35 Million

Kamran Alam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
431,000 Added 25.31%
1,271,937 Common Stock
Feb 02 2024
SELL
Payment of exercise price or tax liability
$1,944 $1.51 p/Share
1,288 Reduced 0.15%
840,937 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
590,413 Added 41.21%
842,225 Common Stock
Aug 24 2023
SELL
Open market or private sale
$76,890 $2.33 p/Share
33,000 Reduced 11.34%
258,042 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
6,230 Added 2.1%
291,042 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
18,691 Added 6.16%
284,812 Common Stock
Aug 23 2022
SELL
Open market or private sale
$11,538 $3.47 p/Share
3,325 Reduced 1.23%
266,121 Common Stock
Aug 22 2022
SELL
Open market or private sale
$34,010 $3.5 p/Share
9,717 Reduced 3.48%
269,446 Common Stock
Aug 19 2022
SELL
Open market or private sale
$43,058 $3.75 p/Share
11,482 Reduced 3.95%
279,163 Common Stock
Aug 18 2022
SELL
Open market or private sale
$28,932 $3.87 p/Share
7,476 Reduced 2.51%
290,645 Common Stock
Aug 20 2021
SELL
Open market or private sale
$200,333 $16.92 p/Share
11,840 Reduced 3.82%
298,121 Common Stock
Aug 19 2021
SELL
Open market or private sale
$167,147 $16.77 p/Share
9,967 Reduced 3.12%
309,961 Common Stock
Aug 18 2021
SELL
Open market or private sale
$194,199 $17.35 p/Share
11,193 Reduced 3.38%
319,928 Common Stock
KA

Kamran Alam

CHIEF FINANCIAL OFFICER
Dallas, TX

Track Institutional and Insider Activities on TSHA

Follow Taysha Gene Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

News

Receive news related to Taysha Gene Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TSHA